People
Alexion Exercises Option for Two Additional GalXC RNAi Programmes for Complement-Mediated Targets Under Collaboration with Dicerna
10 March 2020 - - US-based healthcare company Grail, Inc has appointed Gautam Kollu as chief commercial officer, the company said.

Kollu joins Grail from Illumina, Inc. where he most recently served as vice president, global market development and led the teams that drove the commercial adoption of genomics in multiple applications including noninvasive prenatal testing and liquid biopsy.
Login
Username:

Password: